Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Assessing global and regional Aβ-amyloid deposition in the brain with multiple Aβ-tracers using the Centiloid scale

Victor Villemagne, Samantha Burnham, Pierrick Bourgeat, Vincent Dore, Simon Laws, Olivier Salvado, Jurgen Fripp, Ralph Martins, Colin Masters and Christopher Rowe
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 248;
Victor Villemagne
1Molecular Imaging & Therapy Austin Health Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Burnham
3CSIRO - AEHRC Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierrick Bourgeat
2CSIRO - AEHRC Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Dore
3CSIRO - AEHRC Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Laws
4Edith Cowan University Perth Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Salvado
2CSIRO - AEHRC Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jurgen Fripp
2CSIRO - AEHRC Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph Martins
6McCusker Alzheimer'S Research Foundation Nedlands, Perth Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Masters
5Florey Institute Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Rowe
1Molecular Imaging & Therapy Austin Health Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

248

Background: The aim of the study was to evaluate if Centiloids (CL) generated with different Aβ tracers yielded similar rates of Aβ accumulation, validating its use in multicenter, multitracer anti-Aβ therapeutic trials.

Methods: We used longitudinal Aβ imaging data from the AIBL and ADNI studies to calculate the rates of global and regional Aβ-amyloid deposition. We analyzed 485 participants from AIBL and ADNI (321 HC; 135 MCI; 29 AD) with 3 or more Aβ imaging assessments. While AIBL participants underwent Aβ imaging with PiB and NAV4694 (n=220, median follow-up of 4.8 -range 2.5-10.6- years), or flutemetamol (FLUTE, n=94, median follow-up of 3.2 -range 3.0-3.8- years), ADNI participants underwent Aβ imaging with florbetapir (FBP, n=171, median follow-up of 4.1 -range 2.9-5.7 - years). CL were generated using the CL cortical and whole cerebellum masks. FBP SUVR were first generated using a white matter mask and then converted to whole cerebellum before the CL transformation. Aβ accumulation was derived from the slope of the linear regression plots, and rates of accumulation were calculated from the time it took to go from a threshold 20 CL (Aβ-) to 100 CL (mean levels of Aβ+AD).

Results: Of 485 initial participants, 417 (86%) (270 HC; 118 MCI; 29 AD) showed positive rates of Aβ accumulation over 3 or more assessments. Irrespective of the Aβ tracer used, Aβ deposition spans more than two decades, averaging 22.7±3.9 (mean±SD) years to go from a threshold of 20 CL to 100 CL. Rates of Aβ accumulation were 3.8 CL/yr (5%/yr) for PiB/NAV, 3.6 CL/yr (5%/yr) for FLUTE and 3.0 CL/yr (4%/yr) for FBP, respectively, averaging 3.5±0.4 CL/yr (4.3%/yr) when all tracers are considered together. The regional assessment showed fastest Aβ accumulation in the posterior cingulate/precuneus and frontal areas, and slowest in the hippocampus.

Conclusions: Aβ-amyloid deposition is a slow and protracted process, extending for more than two decades. Centiloids can be used to combine longitudinal Aβ imaging data obtained with different Aβ tracers.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing global and regional Aβ-amyloid deposition in the brain with multiple Aβ-tracers using the Centiloid scale
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Assessing global and regional Aβ-amyloid deposition in the brain with multiple Aβ-tracers using the Centiloid scale
Victor Villemagne, Samantha Burnham, Pierrick Bourgeat, Vincent Dore, Simon Laws, Olivier Salvado, Jurgen Fripp, Ralph Martins, Colin Masters, Christopher Rowe
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 248;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing global and regional Aβ-amyloid deposition in the brain with multiple Aβ-tracers using the Centiloid scale
Victor Villemagne, Samantha Burnham, Pierrick Bourgeat, Vincent Dore, Simon Laws, Olivier Salvado, Jurgen Fripp, Ralph Martins, Colin Masters, Christopher Rowe
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 248;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET quantifies target engagement of MAGL therapeutics for Alzheimer’s disease
  • Molecular Imaging of Neuroinflammation in Alzheimer Disease
  • Multiparametric magnetic resonance imaging and positron emission tomography findings in the diagnosis of primary progressive aphasia – A case based approach and review of literature
Show more Neurosciences

Amyloid and Tau PET

  • Amyloid Load in the Down syndrome population measured with [11C]PiB PET
  • Evaluation of a visual read method for flortaucipir PET Scans
  • Sex Modulates the ApoE ε4 Effect on Tau 18F-AV-1451 PET Imaging in Individuals with Normal Aging and Mild Cognitive Impairment
Show more Amyloid and Tau PET

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire